Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is P  [Clear All Filters]
2023
Wu L, Zhou M, Li Y, Chen X, Mo W, Wang C, Xu S, Zhou W, Deng T, Zhou R, et al. Prospective study of a modified posttransplant cyclophosphamide regimen for severe aplastic anemia patients with HLA-haploidentical transplantation. Transplant Cell Ther. 2023.
Sarkar S, Mishra A, Periasamy S, Dyett B, Dogra P, Ball AS, Yeo LY, White JF, Wang Z, Cristini V, et al. Prospective Subunit Nanovaccine against Infection─Cubosome Lipid Nanocarriers of Cord Factor, Trehalose 6,6' Dimycolate. ACS Appl Mater Interfaces. 2023.
Ngai LLam, Hanekamp D, Janssen F, Carbaat-Ham J, Hofland MAM, Fayed MMHE, Kelder A, van Marsbergen LOudshoorn-, Scholten WJ, Snel AN, et al. Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial. Blood. 2023.
Ning L, Xi J, Zi Y, Chen M, Zou Q, Zhou X, Tang C. Prospects and challenges of CRISPR/Cas9 gene-editing technology in cancer research. Clin Genet. 2023.
Parnham MJ, Norris V, Kricker JA, Gudjonsson T, Page CP. Prospects for macrolide therapy of asthma and COPD. Adv Pharmacol. 2023;98:83-110.
Brännström M, Hellström M. Prospects for use of bioengineered tissue from stem cells in gynecology. Acta Obstet Gynecol Scand. 2023;102(7):808-810.
Artemova D, Vishnyakova P, Gantsova E, Elchaninov A, Fatkhudinov T, Sukhikh G. The prospects of cell therapy for endometriosis. J Assist Reprod Genet. 2023.
Poletti V, Montepeloso A, Pellin D, Biffi A. Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells. Mol Ther Methods Clin Dev. 2023;31:101131.
Lai S-F, Huang W-Y, Wang W-H, Hong J-B, Kuo S-H, Lin S-J. Prostaglandin E2 prevents radiotherapy-induced alopecia by attenuating transit amplifying cell apoptosis through promoting G1 arrest. J Dermatol Sci. 2023.
Mauro D, Srinath A, Guggino G, Nicolaidou V, Raimondo S, Ellis JJ, Whyte JM, Nicoletti MMaddalena, Romano M, Kenna TJohn, et al. Prostaglandin E2/EP4 axis is upregulated in Spondyloarthritis and contributes to radiographic progression. Clin Immunol. 2023:109332.
Giafaglione JM, Crowell PD, Delcourt AML, Hashimoto T, Ha SMin, Atmakuri A, Nunley NM, Dang RMA, Tian M, Diaz JA, et al. Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment. Nat Cell Biol. 2023.
Bernard MJ, Smith CM, Goldstein AS. Prostatic proliferative inflammatory atrophy: welcome to the club. J Pathol. 2023.
Hennes A, Devroe J, De Clercq K, Ciprietti M, Held K, Luyten K, Van Ranst N, Maenhoudt N, Peeraer K, Vankelecom H, et al. Protease secretions by the invading blastocyst induce calcium oscillations in endometrial epithelial cells via the protease-activated receptor 2. Reprod Biol Endocrinol. 2023;21(1):37.
de França BNunes, Gasparoni LMiquelitto, Rovai ESilva, Ambrósio LMacedo Bat, de Mendonça NFelix, Hagy MHideki, Mendoza AHuamán, Sipert CRenata, Holzhausen M. Protease-activated receptor type 2 activation downregulates osteogenesis in periodontal ligament stem cells. Braz Oral Res. 2023;37:e002.
Kegyes D, Gulei D, Drula R, Cenariu D, Tigu B, Dima D, Tanase A, Badelita S, Buzoianu A-D, Ciurea S, et al. Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma. Blood Rev. 2023:101100.
Xue Y, San Luis B, Dress RJ, Murad KBinte Ahma, Ginhoux F, Barker N, Lane D. Proteasome inhibitor bortezomib stabilizes and activates p53 in hematopoietic stem/progenitors and double-negative T cells in vivo. Proc Natl Acad Sci U S A. 2023;120(13):e2219978120.
Yau KPui Sharon, Weerasinghe H, Olivier FAB, Lo TL, Powell DR, Koch B, Beilharz TH, Traven A. The proteasome regulator Rpn4 controls antifungal drug tolerance by coupling protein homeostasis with metabolic responses to drug stress. PLoS Pathog. 2023;19(4):e1011338.
Sekhar VC, Gulia KK, Deepti A, Chakrapani PSBaby, Baby S, Viswanathan G. Protection by Nano-Encapsulated Bacoside A and Bacopaside I in Seizure Alleviation and Improvement in Sleep- In Vitro and In Vivo Evidences. Mol Neurobiol. 2023.
Gravina A, Tediashvili G, Rajalingam R, Quandt Z, Deisenroth C, Schrepfer S, Deuse T. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression. Nat Biotechnol. 2023.
Liu Y, Li Y, Deng Z, Zhao Y, Yuan R, Yang M, Wang L, Fang Y, Ding D, Zhou F, et al. Protective and immunomodulatory effects of mesenchymal stem cells on multiorgan injury in male rats with heatstroke. J Therm Biol. 2023;118:103696.
Mak ML, Reid KT, Crome SQ. Protective and pathogenic functions of innate lymphoid cells in transplantation. Clin Exp Immunol. 2023.
Zhu Y, Weng X, Zhang J, Mao J. Protective effect of additional cathelicidin antimicrobial peptide PR-39 on prosthetic-joint infections. J Orthop Surg (Hong Kong). 2023;31(2):10225536231175237.
Li Q, Bu Y, Shao H, Li W, Zhao D, Wang J. Protective effect of bone marrow mesenchymal stem cell-derived exosomes on cardiomyoblast hypoxia-reperfusion injury through the HAND2-AS1/miR-17-5p/Mfn2 axis. BMC Cardiovasc Disord. 2023;23(1):114.
Sun X, Li M, Huang S, Zhang H, Li K. Protective effect of bone morphogenetic protein-7 induced differentiation of bone marrow mesenchymal stem cells in rat with acute spinal cord injury. Funct Integr Genomics. 2023;23(1):68.
Guo H, Zhao Y, Mu R, Zhang G, Chen S, Cao X, Liu K, Liu Y, Dai B, Zhou Y, et al. The Protective Effect of Chronic Intermittent Hypobaric Hypoxia on Preventing the Destruction of CD34 Haematopoietic Stem Cells in Aplastic Anaemia by Modulating the Th1/Th2 Balance. Stem Cell Rev Rep. 2023.

Pages